Clement Blount Sledge, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Knee Prosthesis | 22 | 2004 | 394 | 1.240 |
Why?
|
| Hip Prosthesis | 29 | 1997 | 920 | 1.160 |
Why?
|
| Joint Prosthesis | 18 | 2004 | 253 | 0.710 |
Why?
|
| Synovial Membrane | 25 | 1998 | 524 | 0.620 |
Why?
|
| Radioisotopes | 11 | 1995 | 495 | 0.610 |
Why?
|
| Arthritis, Rheumatoid | 40 | 1998 | 3763 | 0.580 |
Why?
|
| Dysprosium | 10 | 1994 | 24 | 0.500 |
Why?
|
| Cartilage | 14 | 1991 | 806 | 0.420 |
Why?
|
| Knee Joint | 26 | 2003 | 1663 | 0.420 |
Why?
|
| Arthroplasty, Replacement, Knee | 11 | 2006 | 1370 | 0.390 |
Why?
|
| Hip Joint | 17 | 1999 | 1006 | 0.360 |
Why?
|
| Synovitis | 8 | 1998 | 215 | 0.320 |
Why?
|
| Osteoarthritis | 21 | 2003 | 1055 | 0.310 |
Why?
|
| Cartilage, Articular | 16 | 1998 | 1091 | 0.260 |
Why?
|
| Ferric Compounds | 9 | 1994 | 377 | 0.220 |
Why?
|
| Bone Cements | 8 | 2001 | 324 | 0.220 |
Why?
|
| Orthopedics | 5 | 1995 | 892 | 0.210 |
Why?
|
| Femur | 10 | 1990 | 1302 | 0.200 |
Why?
|
| Evaluation Studies as Topic | 13 | 1996 | 1628 | 0.190 |
Why?
|
| Patella | 7 | 1999 | 313 | 0.190 |
Why?
|
| Arthritis | 8 | 1993 | 666 | 0.190 |
Why?
|
| Proteoglycans | 11 | 1990 | 801 | 0.190 |
Why?
|
| Polyethylenes | 5 | 2004 | 290 | 0.180 |
Why?
|
| Prosthesis Failure | 13 | 2004 | 1206 | 0.160 |
Why?
|
| Shoulder Joint | 5 | 1990 | 732 | 0.150 |
Why?
|
| Interleukin-1 | 7 | 1992 | 1249 | 0.140 |
Why?
|
| Activities of Daily Living | 9 | 2004 | 2417 | 0.140 |
Why?
|
| Cyclic AMP | 3 | 1991 | 1456 | 0.140 |
Why?
|
| Postoperative Complications | 23 | 1999 | 15697 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2002 | 1406 | 0.130 |
Why?
|
| Osseointegration | 2 | 2001 | 274 | 0.130 |
Why?
|
| Reoperation | 16 | 2004 | 4291 | 0.120 |
Why?
|
| Endotoxins | 2 | 1988 | 521 | 0.120 |
Why?
|
| Culture Techniques | 14 | 1988 | 530 | 0.120 |
Why?
|
| Elbow Joint | 2 | 1993 | 356 | 0.120 |
Why?
|
| Radiography | 19 | 1999 | 6965 | 0.120 |
Why?
|
| Prosthesis Design | 9 | 1999 | 2135 | 0.120 |
Why?
|
| Tibia | 8 | 2001 | 1065 | 0.110 |
Why?
|
| Hip Dislocation | 2 | 1995 | 246 | 0.110 |
Why?
|
| Methylmethacrylates | 2 | 1984 | 67 | 0.110 |
Why?
|
| Arthritis, Experimental | 3 | 1989 | 291 | 0.110 |
Why?
|
| Hydrocortisone | 6 | 1988 | 1803 | 0.110 |
Why?
|
| Sodium Pertechnetate Tc 99m | 3 | 1988 | 55 | 0.110 |
Why?
|
| Cattle | 12 | 1997 | 3847 | 0.110 |
Why?
|
| Epiphyses | 4 | 1981 | 190 | 0.110 |
Why?
|
| Collagen | 10 | 1998 | 2636 | 0.100 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1992 | 32 | 0.100 |
Why?
|
| Pain | 13 | 2004 | 5066 | 0.100 |
Why?
|
| Acetabulum | 1 | 1996 | 541 | 0.100 |
Why?
|
| Glycosaminoglycans | 5 | 1998 | 605 | 0.100 |
Why?
|
| Joints | 3 | 1990 | 321 | 0.100 |
Why?
|
| Ankle Joint | 2 | 1994 | 435 | 0.100 |
Why?
|
| beta-Thalassemia | 1 | 1993 | 235 | 0.090 |
Why?
|
| Managed Care Programs | 1 | 1996 | 939 | 0.090 |
Why?
|
| Biocompatible Materials | 4 | 2004 | 1689 | 0.090 |
Why?
|
| Dinoprostone | 4 | 1992 | 598 | 0.090 |
Why?
|
| Radiometry | 2 | 1995 | 813 | 0.090 |
Why?
|
| Rhenium | 1 | 1990 | 14 | 0.090 |
Why?
|
| Synovial Fluid | 5 | 1993 | 395 | 0.090 |
Why?
|
| Follow-Up Studies | 25 | 2004 | 39261 | 0.090 |
Why?
|
| Rabbits | 15 | 1999 | 4773 | 0.090 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1991 | 152 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1995 | 1191 | 0.080 |
Why?
|
| Osteoarthritis, Hip | 1 | 1993 | 406 | 0.080 |
Why?
|
| Sickness Impact Profile | 2 | 2003 | 298 | 0.080 |
Why?
|
| Middle Aged | 52 | 2006 | 220352 | 0.070 |
Why?
|
| Aged | 47 | 2006 | 169152 | 0.070 |
Why?
|
| Terminology as Topic | 2 | 1995 | 1535 | 0.070 |
Why?
|
| Range of Motion, Articular | 4 | 2003 | 1583 | 0.070 |
Why?
|
| Paraplegia | 1 | 1987 | 162 | 0.070 |
Why?
|
| Polymethyl Methacrylate | 2 | 2004 | 131 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 3 | 2006 | 1234 | 0.070 |
Why?
|
| Humans | 96 | 2006 | 760621 | 0.070 |
Why?
|
| Nerve Compression Syndromes | 1 | 1987 | 160 | 0.060 |
Why?
|
| Shoulder | 1 | 1987 | 299 | 0.060 |
Why?
|
| Titanium | 3 | 2004 | 484 | 0.060 |
Why?
|
| Movement | 7 | 1990 | 1474 | 0.060 |
Why?
|
| Equipment Failure | 5 | 1990 | 577 | 0.060 |
Why?
|
| Tissue Distribution | 5 | 1998 | 2262 | 0.060 |
Why?
|
| Liposomes | 1 | 1988 | 777 | 0.060 |
Why?
|
| Adult | 39 | 2006 | 219994 | 0.060 |
Why?
|
| Gait | 4 | 1991 | 812 | 0.050 |
Why?
|
| Pain Measurement | 3 | 2003 | 3528 | 0.050 |
Why?
|
| Health Care Costs | 1 | 1996 | 3258 | 0.050 |
Why?
|
| Dogs | 9 | 1998 | 3841 | 0.050 |
Why?
|
| Complement Activation | 1 | 2004 | 446 | 0.050 |
Why?
|
| Patient Satisfaction | 4 | 2006 | 3448 | 0.050 |
Why?
|
| Methods | 4 | 1990 | 1074 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 1991 | 3157 | 0.050 |
Why?
|
| Iron | 3 | 1986 | 1786 | 0.050 |
Why?
|
| Computer Simulation | 1 | 1995 | 6218 | 0.050 |
Why?
|
| Hip | 2 | 1988 | 251 | 0.050 |
Why?
|
| Acid Phosphatase | 4 | 1974 | 139 | 0.050 |
Why?
|
| Osteitis | 1 | 2001 | 33 | 0.050 |
Why?
|
| Complement System Proteins | 2 | 2004 | 782 | 0.050 |
Why?
|
| Male | 48 | 2006 | 359744 | 0.050 |
Why?
|
| Polyethylene | 2 | 2001 | 186 | 0.050 |
Why?
|
| Aged, 80 and over | 14 | 2006 | 58995 | 0.050 |
Why?
|
| Arthroplasty | 3 | 1980 | 313 | 0.050 |
Why?
|
| Arthrodesis | 1 | 1982 | 186 | 0.050 |
Why?
|
| Bone Resorption | 4 | 1990 | 720 | 0.040 |
Why?
|
| Animals | 43 | 2001 | 167963 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2004 | 397 | 0.040 |
Why?
|
| Time Factors | 13 | 2002 | 40165 | 0.040 |
Why?
|
| Surgical Wound Infection | 4 | 1985 | 1527 | 0.040 |
Why?
|
| Locomotion | 4 | 1990 | 387 | 0.040 |
Why?
|
| Bone Substitutes | 1 | 2001 | 236 | 0.040 |
Why?
|
| Female | 48 | 2006 | 391270 | 0.040 |
Why?
|
| Cost Control | 2 | 1996 | 630 | 0.040 |
Why?
|
| Bone Lengthening | 1 | 1978 | 19 | 0.040 |
Why?
|
| Injections, Intra-Articular | 5 | 1988 | 279 | 0.040 |
Why?
|
| Ossification, Heterotopic | 1 | 2001 | 235 | 0.040 |
Why?
|
| Bacterial Infections | 3 | 1984 | 1403 | 0.040 |
Why?
|
| Pain, Postoperative | 2 | 2006 | 1721 | 0.040 |
Why?
|
| Implants, Experimental | 1 | 1999 | 99 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 1988 | 2145 | 0.040 |
Why?
|
| Radius | 1 | 1981 | 440 | 0.040 |
Why?
|
| Hypotension | 1 | 1984 | 883 | 0.040 |
Why?
|
| Regeneration | 3 | 1997 | 1506 | 0.040 |
Why?
|
| Foreign-Body Reaction | 3 | 1996 | 157 | 0.040 |
Why?
|
| Cell Transplantation | 2 | 1998 | 472 | 0.040 |
Why?
|
| Wound Healing | 3 | 2001 | 2788 | 0.040 |
Why?
|
| Joint Diseases | 2 | 1998 | 457 | 0.040 |
Why?
|
| Radionuclide Imaging | 3 | 1987 | 1975 | 0.040 |
Why?
|
| Cadaver | 2 | 1995 | 1345 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1996 | 2186 | 0.040 |
Why?
|
| Corrosion | 1 | 1996 | 26 | 0.030 |
Why?
|
| Hardness | 1 | 1996 | 35 | 0.030 |
Why?
|
| Foreign-Body Migration | 1 | 1999 | 218 | 0.030 |
Why?
|
| Organometallic Compounds | 2 | 1993 | 662 | 0.030 |
Why?
|
| Life Tables | 1 | 1997 | 365 | 0.030 |
Why?
|
| Elbow | 1 | 1977 | 130 | 0.030 |
Why?
|
| Metals | 2 | 1993 | 736 | 0.030 |
Why?
|
| Osteochondritis | 1 | 1996 | 23 | 0.030 |
Why?
|
| Hyperplasia | 3 | 1996 | 1155 | 0.030 |
Why?
|
| Beta Particles | 1 | 1995 | 47 | 0.030 |
Why?
|
| Hip Fractures | 1 | 1984 | 989 | 0.030 |
Why?
|
| Porphyrins | 1 | 1998 | 353 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 1998 | 286 | 0.030 |
Why?
|
| Osteotomy | 2 | 1978 | 836 | 0.030 |
Why?
|
| Models, Structural | 1 | 1995 | 341 | 0.030 |
Why?
|
| Recurrence | 3 | 1995 | 8482 | 0.030 |
Why?
|
| Documentation | 3 | 1991 | 893 | 0.030 |
Why?
|
| Lysosomes | 4 | 1973 | 920 | 0.030 |
Why?
|
| Mental Recall | 1 | 2001 | 1206 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1988 | 645 | 0.030 |
Why?
|
| Dextrans | 3 | 1987 | 574 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 319 | 0.030 |
Why?
|
| Walking | 2 | 2006 | 1189 | 0.030 |
Why?
|
| Prostaglandins | 2 | 1987 | 398 | 0.030 |
Why?
|
| Cells, Cultured | 8 | 1997 | 18957 | 0.030 |
Why?
|
| Fracture Fixation | 1 | 1996 | 365 | 0.030 |
Why?
|
| Photosensitizing Agents | 1 | 1998 | 618 | 0.030 |
Why?
|
| Pronation | 1 | 1993 | 52 | 0.030 |
Why?
|
| Radiation Dosage | 3 | 1995 | 1958 | 0.030 |
Why?
|
| Supination | 1 | 1993 | 68 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1993 | 132 | 0.030 |
Why?
|
| Treatment Outcome | 9 | 2006 | 65017 | 0.030 |
Why?
|
| Pentetic Acid | 1 | 1993 | 209 | 0.030 |
Why?
|
| Computers | 1 | 1995 | 595 | 0.030 |
Why?
|
| Prostheses and Implants | 2 | 1997 | 1273 | 0.030 |
Why?
|
| Ulnar Nerve | 1 | 1993 | 102 | 0.030 |
Why?
|
| Somatomedins | 1 | 1973 | 178 | 0.030 |
Why?
|
| Meglumine | 1 | 1993 | 145 | 0.030 |
Why?
|
| Plastics | 1 | 1993 | 115 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 1993 | 356 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2000 | 1826 | 0.030 |
Why?
|
| Health Expenditures | 1 | 1985 | 2362 | 0.030 |
Why?
|
| Chondrocytes | 1 | 1997 | 791 | 0.030 |
Why?
|
| Ulna | 1 | 1993 | 134 | 0.030 |
Why?
|
| Ligaments, Articular | 2 | 1986 | 300 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1991 | 10827 | 0.030 |
Why?
|
| Menisci, Tibial | 1 | 1994 | 269 | 0.030 |
Why?
|
| Femoral Fractures | 1 | 1996 | 375 | 0.020 |
Why?
|
| Retrospective Studies | 9 | 1997 | 80372 | 0.020 |
Why?
|
| Sulfates | 5 | 1981 | 379 | 0.020 |
Why?
|
| Veins | 2 | 1988 | 765 | 0.020 |
Why?
|
| Physical Examination | 2 | 1995 | 1244 | 0.020 |
Why?
|
| Particle Size | 4 | 2004 | 1644 | 0.020 |
Why?
|
| Paralysis | 1 | 1993 | 251 | 0.020 |
Why?
|
| Australia | 2 | 2006 | 1289 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 3986 | 0.020 |
Why?
|
| Radiotherapy Dosage | 3 | 1987 | 2897 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 1991 | 2209 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 1998 | 820 | 0.020 |
Why?
|
| Rotation | 1 | 1993 | 514 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2004 | 10182 | 0.020 |
Why?
|
| Bone Development | 2 | 1978 | 472 | 0.020 |
Why?
|
| Humerus | 1 | 1993 | 269 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1973 | 568 | 0.020 |
Why?
|
| Polysaccharides | 3 | 1987 | 1016 | 0.020 |
Why?
|
| Antigens | 2 | 1989 | 1447 | 0.020 |
Why?
|
| Data Collection | 1 | 2000 | 3315 | 0.020 |
Why?
|
| Preoperative Care | 4 | 2001 | 2256 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1995 | 1257 | 0.020 |
Why?
|
| Myositis Ossificans | 1 | 1991 | 77 | 0.020 |
Why?
|
| Recovery of Function | 3 | 2006 | 2985 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1992 | 20509 | 0.020 |
Why?
|
| Materials Testing | 2 | 2004 | 862 | 0.020 |
Why?
|
| Chromatography | 2 | 1983 | 189 | 0.020 |
Why?
|
| Fractures, Bone | 2 | 1993 | 2041 | 0.020 |
Why?
|
| Bone and Bones | 3 | 1974 | 2560 | 0.020 |
Why?
|
| Apatites | 1 | 1968 | 19 | 0.020 |
Why?
|
| Sulfides | 1 | 1990 | 171 | 0.020 |
Why?
|
| Tendons | 1 | 1993 | 552 | 0.020 |
Why?
|
| Cartilage Diseases | 1 | 1990 | 156 | 0.020 |
Why?
|
| Oxyquinoline | 1 | 1988 | 16 | 0.020 |
Why?
|
| Prospective Studies | 6 | 2004 | 54303 | 0.020 |
Why?
|
| Intraoperative Complications | 2 | 1993 | 1186 | 0.020 |
Why?
|
| Indium Radioisotopes | 1 | 1988 | 113 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 1968 | 170 | 0.020 |
Why?
|
| Half-Life | 2 | 1986 | 652 | 0.020 |
Why?
|
| Indium | 1 | 1987 | 46 | 0.020 |
Why?
|
| Tritium | 4 | 1990 | 707 | 0.020 |
Why?
|
| Oxygen | 4 | 1974 | 4193 | 0.020 |
Why?
|
| Thromboembolism | 2 | 1985 | 1017 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1988 | 343 | 0.020 |
Why?
|
| Chick Embryo | 6 | 1974 | 981 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1987 | 100 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1987 | 73 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 1988 | 103 | 0.020 |
Why?
|
| Bucladesine | 1 | 1987 | 118 | 0.020 |
Why?
|
| Lymph Nodes | 3 | 1996 | 3486 | 0.020 |
Why?
|
| Stress, Mechanical | 2 | 1986 | 1666 | 0.020 |
Why?
|
| Theophylline | 1 | 1987 | 131 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 1985 | 5325 | 0.020 |
Why?
|
| Organ Culture Techniques | 2 | 1990 | 796 | 0.020 |
Why?
|
| Arthroscopy | 2 | 1994 | 960 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1993 | 1328 | 0.020 |
Why?
|
| Adolescent | 6 | 1997 | 87810 | 0.020 |
Why?
|
| Arthrography | 1 | 1987 | 149 | 0.020 |
Why?
|
| Salmonella typhi | 1 | 1988 | 199 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1988 | 406 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 20080 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2002 | 1818 | 0.020 |
Why?
|
| Disease Models, Animal | 6 | 1999 | 18137 | 0.020 |
Why?
|
| Permeability | 1 | 1988 | 719 | 0.020 |
Why?
|
| Thymus Gland | 1 | 1990 | 1247 | 0.020 |
Why?
|
| Cell Division | 3 | 1990 | 4463 | 0.020 |
Why?
|
| Bone Regeneration | 1 | 1988 | 432 | 0.020 |
Why?
|
| Bone Marrow | 2 | 1993 | 2912 | 0.020 |
Why?
|
| Liver | 3 | 1986 | 7509 | 0.020 |
Why?
|
| Chondroitin | 2 | 1980 | 64 | 0.020 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 2004 | 9 | 0.020 |
Why?
|
| Synovial Cyst | 1 | 1985 | 35 | 0.020 |
Why?
|
| Manometry | 1 | 1987 | 453 | 0.020 |
Why?
|
| Credentialing | 1 | 1985 | 115 | 0.010 |
Why?
|
| Human Experimentation | 1 | 1985 | 123 | 0.010 |
Why?
|
| Toxicology | 1 | 1965 | 103 | 0.010 |
Why?
|
| Employment | 2 | 1991 | 1112 | 0.010 |
Why?
|
| Nose | 1 | 1988 | 519 | 0.010 |
Why?
|
| Cohort Studies | 4 | 2006 | 41335 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 2 | 1996 | 963 | 0.010 |
Why?
|
| Pressure | 1 | 1987 | 1156 | 0.010 |
Why?
|
| Tissue Culture Techniques | 1 | 1965 | 290 | 0.010 |
Why?
|
| Technetium | 1 | 1984 | 321 | 0.010 |
Why?
|
| Culture Media | 3 | 1990 | 900 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 1983 | 2105 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1995 | 3562 | 0.010 |
Why?
|
| Chemistry | 1 | 1983 | 348 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1983 | 508 | 0.010 |
Why?
|
| Transplantation, Autologous | 2 | 1998 | 2116 | 0.010 |
Why?
|
| Joint Instability | 1 | 1990 | 795 | 0.010 |
Why?
|
| Reference Values | 1 | 1990 | 4925 | 0.010 |
Why?
|
| United States | 5 | 2006 | 72461 | 0.010 |
Why?
|
| Antibodies | 1 | 1990 | 2421 | 0.010 |
Why?
|
| Urologic Diseases | 1 | 1985 | 248 | 0.010 |
Why?
|
| Contracture | 1 | 1985 | 235 | 0.010 |
Why?
|
| Interleukin-1beta | 2 | 1990 | 998 | 0.010 |
Why?
|
| Bone Demineralization Technique | 1 | 2001 | 26 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 848 | 0.010 |
Why?
|
| Thymidine | 2 | 1990 | 299 | 0.010 |
Why?
|
| Quality of Life | 4 | 2004 | 13308 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1965 | 623 | 0.010 |
Why?
|
| Software | 1 | 1995 | 4419 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1993 | 3600 | 0.010 |
Why?
|
| Public Opinion | 1 | 1985 | 481 | 0.010 |
Why?
|
| Naproxen | 2 | 1992 | 100 | 0.010 |
Why?
|
| Brachytherapy | 1 | 1989 | 1238 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1990 | 1796 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1985 | 496 | 0.010 |
Why?
|
| Models, Biological | 4 | 1992 | 9467 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 21392 | 0.010 |
Why?
|
| Polymers | 2 | 1998 | 1621 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1986 | 1677 | 0.010 |
Why?
|
| Femur Head | 1 | 1982 | 297 | 0.010 |
Why?
|
| Calcium Phosphates | 1 | 2001 | 171 | 0.010 |
Why?
|
| Age Factors | 2 | 1990 | 18416 | 0.010 |
Why?
|
| Heparin | 1 | 1968 | 1652 | 0.010 |
Why?
|
| Extremities | 1 | 1966 | 867 | 0.010 |
Why?
|
| Autoradiography | 1 | 1981 | 730 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 1980 | 174 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 2001 | 2094 | 0.010 |
Why?
|
| Health Status | 2 | 1999 | 4081 | 0.010 |
Why?
|
| Kinetics | 1 | 1988 | 6377 | 0.010 |
Why?
|
| Gold Sodium Thiomalate | 1 | 1979 | 10 | 0.010 |
Why?
|
| Hospitals, Proprietary | 1 | 1979 | 39 | 0.010 |
Why?
|
| Ovalbumin | 2 | 1989 | 674 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1991 | 4357 | 0.010 |
Why?
|
| Hospitals, Special | 1 | 1979 | 90 | 0.010 |
Why?
|
| Stifle | 1 | 1998 | 28 | 0.010 |
Why?
|
| Absorbable Implants | 1 | 2001 | 345 | 0.010 |
Why?
|
| Indomethacin | 1 | 1979 | 326 | 0.010 |
Why?
|
| Alloys | 1 | 1999 | 113 | 0.010 |
Why?
|
| Japan | 1 | 2003 | 1369 | 0.010 |
Why?
|
| Electromyography | 1 | 1983 | 1388 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1993 | 9287 | 0.010 |
Why?
|
| Societies, Medical | 1 | 1990 | 3905 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 8056 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2001 | 630 | 0.010 |
Why?
|
| Periosteum | 1 | 1997 | 138 | 0.010 |
Why?
|
| Osteolysis | 1 | 1999 | 274 | 0.010 |
Why?
|
| Collagen Diseases | 1 | 1976 | 39 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1997 | 6238 | 0.010 |
Why?
|
| Knee | 1 | 1978 | 276 | 0.010 |
Why?
|
| Research | 1 | 1965 | 1974 | 0.010 |
Why?
|
| Histiocytosis, Sinus | 1 | 1996 | 46 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2001 | 968 | 0.010 |
Why?
|
| Cell Communication | 2 | 1996 | 1653 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1985 | 1869 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1977 | 881 | 0.010 |
Why?
|
| Bone Matrix | 1 | 1996 | 118 | 0.010 |
Why?
|
| Fractures, Closed | 1 | 1996 | 88 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1984 | 1462 | 0.010 |
Why?
|
| Transplants | 1 | 1997 | 206 | 0.010 |
Why?
|
| Lymphadenitis | 1 | 1996 | 98 | 0.010 |
Why?
|
| Fractures, Open | 1 | 1996 | 105 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1993 | 36290 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 6360 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 941 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1984 | 1407 | 0.010 |
Why?
|
| Phosphoric Acids | 1 | 1974 | 20 | 0.010 |
Why?
|
| Bioprosthesis | 1 | 1998 | 600 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 1722 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1984 | 2255 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1974 | 149 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 2558 | 0.010 |
Why?
|
| Sulfur Isotopes | 1 | 1973 | 21 | 0.010 |
Why?
|
| Hydroxyproline | 2 | 1974 | 110 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1986 | 5508 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1973 | 306 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 1973 | 114 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 1973 | 49 | 0.010 |
Why?
|
| Group Processes | 1 | 1994 | 226 | 0.010 |
Why?
|
| Fibrin | 1 | 1996 | 505 | 0.010 |
Why?
|
| DNA | 2 | 1997 | 7233 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1973 | 297 | 0.010 |
Why?
|
| Surface Properties | 1 | 1996 | 1161 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1986 | 8555 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1974 | 384 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1973 | 700 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1973 | 665 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1975 | 482 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1985 | 3242 | 0.010 |
Why?
|
| Rats | 2 | 2001 | 23711 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1992 | 866 | 0.010 |
Why?
|
| Ribs | 1 | 1973 | 252 | 0.010 |
Why?
|
| Proline | 2 | 1974 | 457 | 0.010 |
Why?
|
| Boston | 1 | 1984 | 9280 | 0.010 |
Why?
|
| Bone Transplantation | 1 | 1996 | 922 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1993 | 1385 | 0.010 |
Why?
|
| Cobalt | 1 | 1990 | 155 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 10551 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1993 | 823 | 0.010 |
Why?
|
| Chromium | 1 | 1990 | 132 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1973 | 559 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1997 | 1726 | 0.010 |
Why?
|
| International Agencies | 1 | 1990 | 244 | 0.010 |
Why?
|
| Water | 1 | 1975 | 1407 | 0.000 |
Why?
|
| Surgical Flaps | 1 | 1997 | 1669 | 0.000 |
Why?
|
| Child | 1 | 1997 | 79806 | 0.000 |
Why?
|
| Mandible | 2 | 1974 | 750 | 0.000 |
Why?
|
| Perfusion | 1 | 1973 | 1376 | 0.000 |
Why?
|
| Cathepsins | 1 | 1968 | 242 | 0.000 |
Why?
|
| Carrageenan | 1 | 1987 | 71 | 0.000 |
Why?
|
| Prognosis | 2 | 2004 | 29658 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1993 | 2025 | 0.000 |
Why?
|
| Physicians | 1 | 1985 | 4591 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1997 | 4090 | 0.000 |
Why?
|
| Dextran Sulfate | 1 | 1987 | 255 | 0.000 |
Why?
|
| Risk Factors | 3 | 2004 | 74359 | 0.000 |
Why?
|
| Length of Stay | 1 | 1999 | 6479 | 0.000 |
Why?
|
| Ascorbic Acid | 1 | 1968 | 655 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3804 | 0.000 |
Why?
|
| Drug Carriers | 1 | 1989 | 709 | 0.000 |
Why?
|
| Vitamin E | 1 | 1968 | 872 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1968 | 1516 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1975 | 2511 | 0.000 |
Why?
|
| Colloids | 1 | 1983 | 122 | 0.000 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1966 | 338 | 0.000 |
Why?
|
| Radioactivity | 1 | 1983 | 58 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11071 | 0.000 |
Why?
|
| Models, Anatomic | 1 | 1986 | 682 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1968 | 1797 | 0.000 |
Why?
|
| Fibrosis | 1 | 1989 | 2042 | 0.000 |
Why?
|
| Ovary | 1 | 1986 | 958 | 0.000 |
Why?
|
| Macrophages | 1 | 1996 | 5745 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1968 | 2414 | 0.000 |
Why?
|
| Microspheres | 1 | 1983 | 787 | 0.000 |
Why?
|
| Contrast Media | 1 | 1993 | 5305 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1983 | 674 | 0.000 |
Why?
|
| Shoes | 1 | 1979 | 94 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1985 | 15757 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11481 | 0.000 |
Why?
|
| Proteins | 1 | 1973 | 6029 | 0.000 |
Why?
|
| Postoperative Care | 1 | 1983 | 1479 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1974 | 140 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1983 | 2415 | 0.000 |
Why?
|
| Rheumatoid Factor | 1 | 1974 | 185 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 557 | 0.000 |
Why?
|
| Parathyroid Glands | 1 | 1974 | 517 | 0.000 |
Why?
|
| Leukocytes | 1 | 1974 | 2026 | 0.000 |
Why?
|